One study used anti-EGFR nanobodies, of approximately 31 kDa, to guide red blood cells vesicles (RBCEVs), and their results revealed high affinity of the construct to EGFR-positive cell lines such as H358 and HCC827 (cancer lung cell lines) (Figure 3). The gene discussed is EGFR; the disease is cancer.